Advertisement
Advertisement

BCAB

BCAB logo

BioAtla Inc

1.17
USD
-0.14
-10.69%
Dec 18, 15:59 UTC -5
Closed
...

BioAtla Inc Profile

About

BioAtla Inc. is a clinical-stage biopharmaceutical company. It engages in developing a novel class of antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla Inc. is based in SAN DIEGO.

Info & Links

CEO

Jay M. Short

Headquarters

11085 TORREYANA ROAD
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

28

Employees

65

BioAtla Inc Statistics

Valuation Measures

Market Capitalization2

56.57M

Enterprise Value

53.50K

Enterprise Value/EBITDA(ttm)

-0.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.05

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-24.06%

Return on Equity(ttm)

-187.30%

Return on Invested Capital(ttm)

-198.09%

Return on Assets(ttm)

-96.33%

Income Statement

Revenue(ttm)

11.00M

Revenue Per Share(ttm)

0.23

Gross Profit(ttm)

11.00M

EBITDA(ttm)3

-85.17M

Net Income Available to Common(ttm)

-81.82M

Diluted EPS(ttm)

-1.70

Share Statistics

Beta (5Y Monthly)

0.96

52-Week Change

-14.60%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

48.35M

Dividend Yield

0.00%

Float4

42.79M

% Held by Insiders

11.50%

% Held by Institutions

77.23%

Balance Sheet

Total Cash(mrq)

56.52M

Total Cash Per Share(mrq)

1.17

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.11%

Quick Ratio(mrq)

3.11%

Book Value Per Share(mrq)

0.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.14

Free Cash Flow(ytd)

-55.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement